| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b876ed3a08bad9994c3d04b06109d43b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7fd38ff393036b78f4fa402ddeeae2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f447826846037ed351bc6d13414f823
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e034db80bcded4c7383e5b8a321234d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8941ad6160af0082a4425ab1bb23a3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6a71ace0f0f290e0d046c308165982e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2004-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f871d675bb73ee275edf8e87ae4d8b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f936a33a27b07dd0a6c72520776dca6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dca67222559562329a6b76e835b4e950
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886a592b2f5eeec8bb4888d7cc99d122 |
| publicationDate |
2004-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004063220-A1 |
| titleOfInvention |
Hydrophilic recombinant gp100 protein and uses thereof for immunotherapy |
| abstract |
The invention relates to a nucleic acid construct comprising a polynucleotide sequence encoding a hydrophilic gp100-derived recombinant protein. The invention further provides a hydrophilic gp100-derived recombinant protein, compositions, methods and uses thereof for the treatment and induction of immune response against a malignant disorder, particularly, melanoma. More specifically, the invention provides methods and compositions for inducing the production of specific both helper and cytotoxic T lymphocytes by using antigen presenting cells (APC) loaded with a hydrophilic gp100-derived recombinant polypeptide, in the treatment of malignancies such as melanoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419928-B2 |
| priorityDate |
2003-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |